Multicentre, randomised, double blind, placebo controlled, phase III study of weekly, low dose, subcutaneous interferon beta-1a in secondary progressive multiple sclerosis.

Research output: Contribution to journalArticle

Details

Authors
  • O Andersen
  • I Elovaara
  • M Färkkilä
  • H J Hansen
  • S I Mellgren
  • K-M Myhr
  • Magnhild Sandberg Wollheim
  • P Soelberg Sørensen
Organisations
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Neurology
Original languageEnglish
Pages (from-to)706-710
JournalJournal of Neurology, Neurosurgery and Psychiatry
Volume75
Issue number5
Publication statusPublished - 2004
Publication categoryResearch
Peer-reviewedYes

Total downloads

No data available